Edgestream Partners »

Apellis Pharmaceuticals shares owned by Edgestream Partners

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $942k 16k 58.78

More positions owned by Edgestream Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Apple (AAPL)
McKesson Corporation (MCK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
AmerisourceBergen (COR)
Phillips Edison & Co Common Stock (PECO)
Republic Services (RSG)
Targa Res Corp (TRGP)
Bellring Brands Common Stock (BRBR)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Edgestream Partners

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Jennison Associates
Octagon Capital Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
FMR
Assenagon Asset Management
Boxer Capital
Geode Capital Management
Morgan Stanley

View all funds holding Apellis Pharmaceuticals